TScan Therapeutics (TCRX) Times Interest Earned (2020 - 2026)
TScan Therapeutics' (TCRX) quarterly Times Interest Earned came in at -$42.29 in Q1 2026, up 20.78% year-on-year from -$35.01 in Q1 2025, and down 85.06% on a QoQ basis from -$22.85 in Q4 2025.
TScan Therapeutics (TCRX) Times Interest Earned (2020 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has 7 years of Times Interest Earned data on file, last reported at -$42.29 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 20.78% year-over-year to -$42.29 in Q1 2026; TTM through Mar 2026 was -$41.24, a 0.43% change from a year earlier, with the FY2025 full-year figure at -$1.62, up 88.25% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$42.29, down from -$22.85 in the prior quarter.
- Over the last five years, Times Interest Earned for TCRX reached as high as -$3.29 in Q4 2023 and fell as low as -$82.48 in Q3 2022.
- Historically, Times Interest Earned has averaged -$36.51 across 5 years, with a median of -$34.05 in 2024.
- Across the five-year window, Times Interest Earned slumped 4820.96% in 2022 and jumped 69.44% in 2023, its largest moves.
- Year by year, Times Interest Earned stood at -$10.37 in 2022, then soared by 68.27% to -$3.29 in 2023, then sank by 1323.63% to -$46.83 in 2024, then jumped by 51.2% to -$22.85 in 2025, then plunged by 85.06% to -$42.29 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$42.29 in Q1 2026, -$22.85 in Q4 2025, and -$53.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | -42.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.29 |
| Dec 31, 2025 | -22.85 |
| Sep 30, 2025 | -53.01 |
| Jun 30, 2025 | -56.10 |
| Mar 31, 2025 | -53.39 |
| Dec 31, 2024 | -46.83 |
| Sep 30, 2024 | -34.05 |
| Jun 30, 2024 | -35.83 |
| Mar 31, 2024 | -32.71 |
| Dec 31, 2023 | -3.29 |
| Sep 30, 2023 | -25.20 |
| Jun 30, 2023 | -25.40 |
| Mar 31, 2023 | -23.79 |
| Dec 31, 2022 | -10.37 |
| Sep 30, 2022 | -82.48 |
| Dec 31, 2021 | -6.70 |
| Sep 30, 2021 | -1.68 |
| Jun 30, 2021 | -0.48 |
| Dec 31, 2020 | -2.06 |